New antibiotic class battles resistant infections
February 7th 2005The healthcare community faces an increasing clinical challenge in preventing and controlling the growing emergence of resistant organisms. Tigecycline (Tygacil, Wyeth) is one of a slim list of new antibiotics in development that shows substantial promise as a broad-spectrum agent with activity against many resistant gram-positive bacteria and, to a lesser extent, gram-negative bacteria.
New guidelines declare all inhalers are comparable
February 7th 2005The number of different devices for delivering inhaled medications has multiplied in the past two to three decades. Dozens of new products have hit the market since the 1970s. While the bounty of choices gives prescribers the flexibility to meet their patients' needs, information guiding prescribers through device selection was not readily available until recently.
Guidelines raise awareness of childhood migraine
February 7th 2005Migraine headaches are common in children and occur with increasing frequency through adolescence. The reported prevalence increases from 3% (age three to seven years) to 4%-11% (age seven to 11 years) to 8%-23% (age 11 to 15 and up). The mean age at onset is 7.2 years for boys and 10.9 years for girls.
Changes to 340B program help small, rural hospitals
January 24th 2005Medicare reform has produced an unexpected crop of beneficiaries. Hundreds of rural and small urban hospitals are eligible to join the 340B drug discount program thanks to the 2003 Medicare law. Savings depend on the details of each hospital's drug spend, but more than half of 340B participants reported saving more than 30% in a recent survey.
How technology can create, and reduce, drug errors
January 24th 2005Of overall computer entry errors, 56% are caused by distractions, according to a U.S. Pharmacopoeia 2003 MEDMARX study. In addition, distractions were cited in 78% of computerized physician order entry (CPOE) errors in reports "that documented a contributing factor other than 'none,'" said John Santell, director of educational program initiatives for the U.S. Pharmacopoeia in Rockville, Md.
Seattle hospital lauded for swift response to fatal error
January 24th 2005Virginia Mason Medical Center in Seattle didn't waste any time issuing a public apology when a 69-year-old patient died as a result of a preventable error. The tragedy occurred when the patient was injected with the antiseptic skin prep solution chlorhexidine instead of a contrast medium designed for radiological procedures. Both solutions were clear and available in the sterile field in unlabeled basins at the time of occurrence.
Most R.Ph.s support new med management standards
January 24th 2005If you have a leaky pipe, you call a plumber, not an electrician. Similarly, if you are in a hospital and receiving prescription drugs, having a pharmacist—the drug expert—review your medication orders is the right thing to do. Certainly, the Joint Commission on Accreditation of HealthCare Organizations thinks so.
Setting up a medication reconciliation system
January 24th 2005Coming soon to a hospital near you: medication reconciliation. That's the directive from the Joint Commission on Accreditation of Healthcare Organizations, which made medication reconciliation one of a dozen National Patient Safety Goals for 2005. JCAHO surveyors started looking for evidence of compliance on Jan. 3.
Will DrugMax hit the jackpot at Mohegan Sun?
January 24th 2005Picture this. Ten thousand employees of a large casino are required to park their car in a nearby seven-storey garage. On the main floor of the garage there is an employee center that houses a fitness center, a branch of the local hospital, a bank, computer center, training center, travel agency, dry cleaner, and a pharmacy.
New guide for surveyors generating concern
January 24th 2005Proposed changes to the nursing facility State Operations Manual are well-meaning but far from ideal. That's the reaction from consultant pharmacists who have studied the latest proposals from the Centers for Medicare & Medicaid Services (CMS).
More states target techs, NABP survey finds
January 24th 2005A recent trend toward greater oversight of technicians continued last year as more state pharmacy boards acted to bring the pharmacist's chief helper into the regulatory fold, according to the 2005 National Association of Boards of Pharmacy Survey of Pharmacy Law.
HHS releases updated adult antiretroviral guidelines
January 24th 2005The human immunodeficiency virus (HIV) may be the closest thing to a perfect virus we have encountered. It is variable, it destroys the patient's defenses, it can hide, and it allows time to spread before it kills. Fortunately, it is not highly infectious. Over the past year, there have been a multitude of clinical trials studying various antiretroviral therapies resulting in an accumulation of data. So much so that the Department of Health & Human Services (HHS) has released its newly revised Guidelines for Antiretroviral Agents in HIV-1 Infected Adults and Adolescents for review and comment even though it released the last version just this past March.
Sleep aid is first agent not limited to short-term use
January 24th 2005Insomnia is one of the most common sleep disturbances in the United States, affecting an estimated 100 million Americans. According to the 2002 Sleep in America poll from the National Sleep Foundation, 58% of adults experience symptoms of insomnia a few nights or more per week at some point in their lives. The total economic costs associated with insomnia have been estimated at $17.5 billion.
Medicare sets up 34 regions for Rx drug plans
January 10th 2005Pharmacy groups that had been hoping the Centers for Medicare & Medicaid Services (CMS) would set up each state as a separate Medicare prescription drug plan (PDP) region got half a loaf. The agency named 25 states as stand-alone areas, but the rest were grouped into nine regions to be served by plans offering the Rx benefit beginning January 2006.
Entecavir shows promise for chronic hepatitis B
January 10th 2005Hepatitis B virus (HBV) is a major healthcare problem around the world. It is estimated that 350 million to 400 million people are chronically infected. The development and approval of oral antihepatitis B virus agents, lamivudine, and, more recently, adefovir dipivoxil, revolutionized the treatment of chronic hepatitis B. However, the emergence of resistant HBV mutants remains the main factor limiting the efficacy of antiviral therapy.With lamivudine, the problem of resistance is very frequent and progressively increases with prolongation of therapy (> 50% at three years).
Chain executive covers ABCs and Part D of Medicare
January 10th 2005If you think the Medicare discount cards were confusing when they took effect last year, wait till the Part D drug benefit starts up in 2006, warned Philip Burgess, R.Ph., national director of pharmacy affairs at Walgreen Co. It might be a good idea for community pharmacists to take cover on Jan. 1, 2006, or better still, go on leave for the whole month of January, he quipped.
FDA Safety Page: Allergic reactions associated with food
January 10th 2005Do you routinely check the inactive ingredients of a drug product? Do you routinely ask patients about food allergies in addition to drug-related allergies? If you answered no to these questions, then you may not be aware that some patients with food allergies may have allergic reactions to ingredients in some drug products.
Legal Q & A: What responsibilities can be delegated to techs?
January 10th 2005Regarding the practice of having pharmacy technicians call for verification/ clarification of prescriptions over illegible drug name, strength, quantity, refills, and directions, I live in Illinois and have worked for an organization that allows this. I am curious to know if the laws were being followed or violated.
Buy-in needed for second modern drug for alcoholism
January 10th 2005There's help coming for those who have resolved to quit drinking in the new year. With the pending release of the second drug in the past half century to treat alcoholism, researchers say the whole treatment field may be at a tipping point.